SEC Info - Ma-Weaver Jacob, et al. - ‘4’ for 12/15/22 re: ARCA biopharma, Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Funicular Funds, LP

(Last)

(First)

(Middle)

2261 MARKET STREET

#4307

(Street)

SAN FRANCISCO

94114

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ARCA biopharma, Inc. [ ABIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)	X	Other (specify below)
See Footnote 1

3. Date of Earliest Transaction (Month/Day/Year)
12/15/22

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ⁽¹⁾	12/16/22		X		1,420,000	A	$2.5	4,000,452	D ⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy) ⁽¹⁾	$2.32	12/15/22		A		6,000		⁽³⁾	12/15/32	Common Stock	6,000 ⁽⁴⁾	$0	18,000	D ⁽²⁾
Put Option ⁽¹⁾	$2.5	12/16/22		X			14,200	12/16/22	12/16/22	Common Stock	1,420,000	$0	30,000	D ⁽²⁾
Put Option ⁽¹⁾	$2.5	12/16/22		E			300	12/16/22	12/16/22	Common Stock	30,000	$0	0	D ⁽²⁾

1. Name and Address of Reporting Person^*

Funicular Funds, LP

(Last)

(First)

(Middle)

2261 MARKET STREET

#4307

(Street)

SAN FRANCISCO

94114

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Ma-Weaver Jacob

(Last)

(First)

(Middle)

2261 MARKET STREET

#4307

(Street)

SAN FRANCISCO

94114

(City)

(State)

(Zip)

Explanation of Responses:

(1) This Form 4 is filed by Funicular Funds, LP (the "Fund") and Jacob Ma-Weaver ("Mr. Ma-Weaver" and together with the Fund, the "Reporting Persons"). The Reporting Persons, the Funicular Fund ("Funicular") and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons, Funicular and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

(2) Represents securities directly owned by the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly ownedby the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, asthe Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.

(3) Grant to Mr. Ma-Weaver of a stock option under the 2020 Equity Incentive Plan (the "Plan"), vesting in 12 equal monthly installments beginning as of December 15, 2022. If Mr. Ma-Weaver's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.

(4) Pursuant to the terms of the Plan, the stock option may not be transferred. Upon vesting, Mr. Ma-Weaver intends on exercising the option and assigning the underlying shares to the Fund.

	/s/ Jacob Ma-Weaver	12/19/22
	Funicular Funds, LP, By: /s/ Jacob Ma-Weaver, Managing Member of the General Partner	12/19/22
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Codes:
A	Grant, award or other acquisition pursuant to Rule 16b-3(d).
E	Expiration of short derivative position.
X	Exercise of in-the-money or at-the-money derivative security.

Ma-Weaver Jacob, et al. – ‘4’ for 12/15/22 re: ARCA biopharma, Inc.

On: Monday, 12/19/22, at 5:33pm ET · For: 12/15/22 · As: Director, 10% Owner and Other · Accession #: 921895-22-3245 · File #: 0-22873

Previous ‘4’: ‘4’ on 6/21/22 for 6/15/22 · Next: ‘4’ on 9/22/23 for 9/20/23 · Latest: ‘4’ on 1/31/24 for 1/30/24

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Ma-Weaver Jacob, et al. – ‘4’ for 12/15/22 re: ARCA biopharma, Inc.

On: Monday, 12/19/22, at 5:33pm ET · For: 12/15/22 · As: Director, 10% Owner and Other · Accession #: 921895-22-3245 · File #: 0-22873

Previous ‘4’: ‘4’ on 6/21/22 for 6/15/22 · Next: ‘4’ on 9/22/23 for 9/20/23 · Latest: ‘4’ on 1/31/24 for 1/30/24

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents